🇺🇸 FDA
Patent

US 6720335

Sulfonamide inhibitors of aspartyl protease

expired A61KA61K38/00

Quick answer

US patent 6720335 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00